Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Viamet Pharmaceuticals Inc.
DescriptionOral small molecule inhibitor of fungal cytochrome P450 C-14 alpha demethylase (CYP51), which blocks production of ergosterol, a fungal cell wall component
Molecular Target Cytochrome P450 C-14 alpha demethylase (CYP51)
Mechanism of ActionCytochrome P450 C-14 alpha demethylase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today